209 related articles for article (PubMed ID: 33155691)
21. Muscle MRI findings in siblings with juvenile-onset acid maltase deficiency (Pompe disease).
Dlamini N; Jan W; Norwood F; Sheehan J; Spahr R; Al-Sarraj S; Anthony Hulse J; Hughes D; Champion MP; Jungbluth H
Neuromuscul Disord; 2008 May; 18(5):408-9. PubMed ID: 18434155
[No Abstract] [Full Text] [Related]
22. Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.
Montagnese F; Barca E; Musumeci O; Mondello S; Migliorato A; Ciranni A; Rodolico C; De Filippi P; Danesino C; Toscano A
J Neurol; 2015; 262(4):968-78. PubMed ID: 25673129
[TBL] [Abstract][Full Text] [Related]
23. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
[TBL] [Abstract][Full Text] [Related]
24. The emerging phenotype of late-onset Pompe disease: A systematic literature review.
Chan J; Desai AK; Kazi ZB; Corey K; Austin S; Hobson-Webb LD; Case LE; Jones HN; Kishnani PS
Mol Genet Metab; 2017 Mar; 120(3):163-172. PubMed ID: 28185884
[TBL] [Abstract][Full Text] [Related]
25. Muscle ultrasound in classic infantile and adult Pompe disease: a useful screening tool in adults but not in infants.
Vill K; Schessl J; Teusch V; Schroeder S; Blaschek A; Schoser B; Müller-Felber W
Neuromuscul Disord; 2015 Feb; 25(2):120-6. PubMed ID: 25455803
[TBL] [Abstract][Full Text] [Related]
26. Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations.
Case LE; Beckemeyer AA; Kishnani PS
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):69-79. PubMed ID: 22252989
[TBL] [Abstract][Full Text] [Related]
27. Physical therapy management of Pompe disease.
Case LE; Kishnani PS
Genet Med; 2006 May; 8(5):318-27. PubMed ID: 16702883
[TBL] [Abstract][Full Text] [Related]
28. Bright tongue sign in patients with late-onset Pompe disease.
Karam C; Dimitrova D; Yutan E; Chahin N
J Neurol; 2019 Oct; 266(10):2518-2523. PubMed ID: 31256280
[TBL] [Abstract][Full Text] [Related]
29. Late-onset Pompe disease in a 54 year-old sportsman with an episode of syncope: a case report.
Walczak-Galezewska M; Skrypnik D; Szulinska M; Musialik K; Skrypnik K; Bogdanski P
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3665-3667. PubMed ID: 28925476
[TBL] [Abstract][Full Text] [Related]
30. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
[TBL] [Abstract][Full Text] [Related]
31. High-density CT of muscle and liver may allow early diagnosis of childhood-onset Pompe disease.
Ishigaki K; Yoshikawa Y; Kuwatsuru R; Oda E; Murakami T; Sato T; Saito T; Umezu R; Osawa M
Brain Dev; 2012 Feb; 34(2):103-6. PubMed ID: 21704464
[TBL] [Abstract][Full Text] [Related]
32. Muscle diffusion MRI reveals autophagic buildup in a mouse model for Pompe disease.
Rohm M; Russo G; Helluy X; Froeling M; Umathum V; Südkamp N; Manahan-Vaughan D; Rehmann R; Forsting J; Jacobsen F; Roos A; Shin Y; Schänzer A; Vorgerd M; Schlaffke L
Sci Rep; 2023 Dec; 13(1):22822. PubMed ID: 38129558
[TBL] [Abstract][Full Text] [Related]
33. Rare Variants in Autophagy and Non-Autophagy Genes in Late-Onset Pompe Disease: Suggestions of Their Disease-Modifying Role in Two Italian Families.
Napolitano F; Bruno G; Terracciano C; Franzese G; Palomba NP; Scotto di Carlo F; Signoriello E; De Blasiis P; Navarro S; Gialluisi A; Melone MAB; Sampaolo S; Esposito T
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807278
[TBL] [Abstract][Full Text] [Related]
34. Adult onset glycogen storage disease type II (adult onset Pompe disease): report and magnetic resonance images of two cases.
Del Gaizo A; Banerjee S; Terk M
Skeletal Radiol; 2009 Dec; 38(12):1205-8. PubMed ID: 19771425
[TBL] [Abstract][Full Text] [Related]
35. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.
Van den Hout JM; Kamphoven JH; Winkel LP; Arts WF; De Klerk JB; Loonen MC; Vulto AG; Cromme-Dijkhuis A; Weisglas-Kuperus N; Hop W; Van Hirtum H; Van Diggelen OP; Boer M; Kroos MA; Van Doorn PA; Van der Voort E; Sibbles B; Van Corven EJ; Brakenhoff JP; Van Hove J; Smeitink JA; de Jong G; Reuser AJ; Van der Ploeg AT
Pediatrics; 2004 May; 113(5):e448-57. PubMed ID: 15121988
[TBL] [Abstract][Full Text] [Related]
36. Novel approaches to quantify CNS involvement in children with Pompe disease.
Korlimarla A; Spiridigliozzi GA; Crisp K; Herbert M; Chen S; Malinzak M; Stefanescu M; Austin SL; Cope H; Zimmerman K; Jones H; Provenzale JM; Kishnani PS
Neurology; 2020 Aug; 95(6):e718-e732. PubMed ID: 32518148
[TBL] [Abstract][Full Text] [Related]
37. Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients.
Reyes-Leiva D; Alonso-Pérez J; Mayos M; Nuñez-Peralta C; Llauger J; Belmonte I; Pedrosa-Hernández I; Segovia S; Díaz-Manera J
Front Neurol; 2021; 12():621257. PubMed ID: 33732206
[No Abstract] [Full Text] [Related]
38. Quantification of muscle pathology in infantile Pompe disease.
Schänzer A; Kaiser AK; Mühlfeld C; Kulessa M; Paulus W; von Pein H; Rohrbach M; Viergutz L; Mengel E; Marquardt T; Neubauer B; Acker T; Hahn A
Neuromuscul Disord; 2017 Feb; 27(2):141-152. PubMed ID: 27927596
[TBL] [Abstract][Full Text] [Related]
39. White matter lesions in treated late onset Pompe disease are not different to matched controls.
Schneider I; Hensel O; Zierz S
Mol Genet Metab; 2019 Jun; 127(2):128-131. PubMed ID: 31153821
[TBL] [Abstract][Full Text] [Related]
40. MRI changes in diaphragmatic motion and curvature in Pompe disease over time.
Harlaar L; Ciet P; van Tulder G; van Kooten HA; van der Beek NAME; Brusse E; de Bruijne M; Tiddens HAWM; van der Ploeg AT; van Doorn PA
Eur Radiol; 2022 Dec; 32(12):8681-8691. PubMed ID: 35829785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
